Shiquan Dabu Pill
Natural health product licensed in Canada
- Other names
- Shiquan Dabu Wan
- Licence holder
- Beijing Kingbird Pharmaceutical Technology Development Co.,Ltd.
- NPN or DIN-HM
- 80124742
- Status
- Active licence
- Licence date
- 2 June 2023
- Revision date
- 24 September 2026
- Form
- Pilule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cinnamomum aromaticum Source : Cinnamomum aromaticum - Écorce interne (tige) | 115 mg | Not calculated |
| Atractylodes macrocephala | 460 mg | Not calculated |
| Angelica sinensis Source : Angelica sinensis - Racine | 690 mg | Not calculated |
| Codonopsis pilosula Source : Codonopsis pilosula - racine | 460 mg | Not calculated |
| Ligusticum sinense cv. chuanxiong Source : Ligusticum sinense cv. chuanxiong - Rhizome | 230 mg | Not calculated |
| Wolfiporia extensa | 460 mg | Not calculated |
| Glycyrrhiza glabra | 230 mg | Not calculated |
| Paeonia lactiflora | 460 mg | Not calculated |
| Rehmannia glutinosa | 690 mg | Not calculated |
| Astragalus membranaceus Source : Astragalus membranaceus - racine | 460 mg | Not calculated |
Non-medicinal ingredients
Miel
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Pilule | minimum: 2 days ; maximum: 3 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Combination of Traditional Chinese Medicine Ingredients. Remedy/Product/Preparation based on the theory of Traditional Chinese Medicine. Traditional Chinese medicine to help pattern of qi and blood deficiency. It is used for manifested as pale complexion, shortness of breath, palpitations, dizziness, spontaneous sweating, fatigue, lack of strength, cold limbs, and heavy menstruation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80124742
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.